News & Events

iMatch ATTC given boost for expanding use of cell and gene therapies in the UK

News External April 4th, 2019
Robert Hawkin

The SAMPLE programme (Standard Approach to atMP tissue colLEction), a vital programme to help build capacity for the NHS to expand the use of a new generation of cell and gene therapies for cancer and non-cancer illnesses has been given the green light by Innovate UK, the UK's innovation agency.

An award made by Innovate UK, through the Industrial Strategy Challenge Fund is supporting the SAMPLE programme, a project to standardise the way cell and gene samples are collected to then be modified to become Advanced Therapy Medicinal Products (ATMPs).

The project will be led by a team of researchers from The Christie, part of the Manchester Cancer Research Centre. This team will be working with a nationwide consortium of NHS Trusts (Manchester University NHS Foundation Trust, Guy's and St. Thomas' NHS Foundation Trust, Newcastle upon Tyne), NHS Blood and Transplant and the Scottish National Blood Transfusion Service and industrial partners Asymptote, TrakCel, Immetacyte and Autolus. The Cell and Gene Therapy Catapult, a centre of excellence in innovation, with the core purpose of building a world-leading cell and gene therapy sector in the UK, will support the project in its role of coordinator of the Advanced Therapy Treatment Centre Network.

Read More

T-cell mediated immunotherapies for cancer

News External Talk August 24, 2016
Robert Hawkin

Watch our CEO, Prof. Robert Hawkins discuss T-cell mediated immunotherapies for cancer as part of the Oncology at the Limits series in the Lancet...

Read More

T-CELL: The tiny superhero feared by the worst villain of all

External Talk July 24, 2016

Hear from CEO Prof. Hawkins and NED Dr. Neil Mackenzie as they discuss the use of T-cell immunotherapy to treat cancer patients with GE Healthcare's 'The Pulse'...

Read More